Patients with obsessive-compulsive disorder who were well after exposure/response prevention therapy often could discontinue a serotonin reuptake inhibitor and have similar outcomes to those who continued an SRI.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
